Cell-Based Phenotypic Screen for Antifibrotic Compounds Targets Eicosanoid Metabolism. | Circ Res;132(1): 30-33, 2023 01 06. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Advanced Search EVID@Easy

Cell-Based Phenotypic Screen for Antifibrotic Compounds Targets Eicosanoid Metabolism.

Lighthouse, Janet K; Small, Eric M.

Affiliation

Lighthouse JK; Wegmans School of Pharmacy, Department of Pharmaceutical Sciences, St. John Fisher University, Rochester, NY (J.K.L.).
Small EM; Aab Cardiovascular Research Institute, Department of Medicine, University of Rochester School of Medicine and Dentistry, NY (J.K.L., E.M.S.).

Circ Res ; 132(1): 30-33, 2023 01 06.

Article in En | MEDLINE | ID: mdl-36603069

Subject(s)
Key words

Editorials; extracellular matrix; fibrosis; heart failure; myocardial infarction

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Eicosanoids / Myocardium Limits: Humans Language: En Journal: Circ Res Year: 2023 Document type: Article Country of publication: Estados Unidos

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Eicosanoids / Myocardium Limits: Humans Language: En Journal: Circ Res Year: 2023 Document type: Article Country of publication: Estados Unidos